Mesenchymal stem cell-derived extracellular vesicles for kidney repair: current status and looming challenges
Open Access
- 4 December 2017
- journal article
- review article
- Published by Springer Science and Business Media LLC in Stem Cell Research & Therapy
- Vol. 8 (1), 1-12
- https://doi.org/10.1186/s13287-017-0727-7
Abstract
Novel therapies are urgently needed to address the rising incidence and prevalence of acute kidney injury (AKI) and chronic kidney disease (CKD). Mesenchymal stem/stromal cells (MSCs) have shown promising results in experimental AKI and CKD, and have been used in the clinic for more than a decade with an excellent safety profile. The regenerative effects of MSCs do not rely on their differentiation and ability to replace damaged tissues, but are primarily mediated by the paracrine release of factors, including extracellular vesicles (EVs), composed of microvesicles and exosomes. MSC-derived EVs contain genetic and protein material that upon transferring to recipient cells can activate several repair mechanisms to ameliorate renal injury. Recent studies have shown that MSC-derived EV therapy improved renal outcomes in several animal models of AKI and CKD, including ischemia-reperfusion injury, drug/toxin-induced nephropathy, renovascular disease, ureteral obstruction, and subtotal nephrectomy. However, data about the renoprotective effects of EV therapy in patients with renal failure are scarce. This review summarizes current knowledge of MSC-derived EV therapy in experimental AKI and CKD, and discusses the challenges that need to be addressed in order to consider MSC-derived EVs as a realistic clinical tool to treat patients with these conditions.Keywords
Funding Information
- National Institute of Diabetes and Digestive and Kidney Diseases (HL123160, DK102325)
This publication has 73 references indexed in Scilit:
- World Incidence of AKIClinical Journal of the American Society of Nephrology, 2013
- Bone Marrow-Derived Mesenchymal Stem Cells Repaired but Did Not Prevent Gentamicin-Induced Acute Kidney Injury through Paracrine Effects in RatsPLOS ONE, 2012
- Importance of RNA isolation methods for analysis of exosomal RNA: Evaluation of different methodsMolecular Immunology, 2012
- Microvesicles Derived from Mesenchymal Stem Cells Enhance Survival in a Lethal Model of Acute Kidney InjuryPLOS ONE, 2012
- Different populations and sources of human mesenchymal stem cells (MSC): A comparison of adult and neonatal tissue-derived MSCCell Communication and Signaling, 2011
- Mesenchymal Stem Cell-Derived Microvesicles Protect Against Acute Tubular InjuryJournal of the American Society of Nephrology, 2009
- Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statementCytotherapy, 2006
- Acute Kidney Injury, Mortality, Length of Stay, and Costs in Hospitalized PatientsJournal of the American Society of Nephrology, 2005
- Kidney Disease as a Risk Factor for Development of Cardiovascular DiseaseHypertension, 2003
- Hospital-acquired renal insufficiencyAmerican Journal of Kidney Diseases, 2002